NCT04673058

Brief Summary

The aim of this study is to evaluate whether spinal manipulation, which is a potential treatment method for musculoskeletal pain, has an additional contribution in patients with fibromyalgia receiving standard pharmacological treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 7, 2020

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 17, 2020

Completed
1 month until next milestone

Study Start

First participant enrolled

January 26, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2021

Completed
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 26, 2021

Completed
Last Updated

October 27, 2021

Status Verified

October 1, 2021

Enrollment Period

9 months

First QC Date

December 7, 2020

Last Update Submit

October 26, 2021

Conditions

Keywords

fibromyalgiamanipulationmanual therapyspinal

Outcome Measures

Primary Outcomes (1)

  • Change from Baseline Pain Intensity at 1 and 3 months

    Patients will be asked to mark their pain on the visual analog scale (VAS) during each visits.

    Baseline, one week after the last treatment session (1st month) and 3rd month

Secondary Outcomes (4)

  • Change from Baseline Tenderness (tender point pain threshold score) at 1 and 3 months

    Baseline, one week after the last treatment session (1st month) and 3rd month

  • Change from Baseline Revised Fibromyalgia Impact Questionnaire (FIQR) at 1 and 3 months

    Baseline, one week after the last treatment session (1st month) and 3rd month

  • Change from Baseline Pain Extent at 1 and 3 months

    Baseline, one week after the last treatment session (1st month) and 3rd month

  • Change from Baseline Fibromyalgia Severity Score (FSS) at 1 and 3 months

    Baseline, one week after the last treatment session (1st month) and 3rd month

Study Arms (3)

Spinal Manipulation Group

EXPERIMENTAL

After the patients were evaluated in terms of somatic dysfunction, the appropriate techniques of Cervical Upglide Thrust, Cervical Downglide Thrust, Cervical Traction Thrust, Cervical Rotation Thrust, Cervico-Thoracic Distraction Manipulation, Cervico-Thoracic Lateral Glide (Spinous Push) Manipulation, Supine Screw Thoracic Thrust, Prone Thoracic Thrust, and Lumbar Spine Rotation Manipulation will be applied to patients.

Procedure: Spinal Manipulation

Sham Manipulation Group

SHAM COMPARATOR

A treatment will be applied which is very similar to active treatment but aimed to have minimal therapeutic effect. For this, the practitioner will primarily identify the areas where somatic dysfunction is detected and keep the application away from these areas. The patient will be positioned for treatment as in active therapy, but once in the lock position, a lower thrust will be given by releasing some back from the position. In this way, the movement will be imitated without reaching the elastic zone and a stronger similarity will be provided compared to sham treatments such as light touch or massage.

Procedure: Sham Manipulation

No Intervention Group

NO INTERVENTION

These patients will receive only their pharmacological treatments.

Interventions

Intervention will be administered twice a week for 3 weeks. Each treatment session will be given in 20-minute sessions consisting of 10 minutes of manual examination and 10 minutes of manual treatment.

Also known as: high velocity low amplitude thrust manipulation
Spinal Manipulation Group

The practitioner will primarily identify the areas where somatic dysfunction is detected and keep the application away from these areas. The patient will be positioned for treatment as in active therapy, but once in the lock position, a lower thrust will be given by releasing some back from the position.

Sham Manipulation Group

Eligibility Criteria

Age18 Years - 55 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale Patients
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Being diagnosed with fibromyalgia according to the 2016 ACR Fibromyalgia Diagnostic Criteria
  • Having been receiving pharmacological treatment for fibromyalgia for at least 2 weeks
  • VAS pain score\> 4

You may not qualify if:

  • Structural problem of the musculoskeletal system (acute spinal disc herniation, acute spondylolisthesis / lysis, fractures and dislocations, advanced degenerative changes, spinal stenosis)
  • Pregnancy or breastfeeding
  • Inflammatory or infectious disease
  • Malignancy
  • Neuromuscular disease
  • History of spinal surgery
  • Unstable psychiatric disease
  • Previously received manual therapy or having enough information about manual therapy to distinguish between sham and real therapy (researched online, watched videos…).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bezmialem Vakif University Hospital

Istanbul, Turkey (Türkiye)

Location

Related Publications (6)

  • Haavik-Taylor H, Murphy B. Cervical spine manipulation alters sensorimotor integration: a somatosensory evoked potential study. Clin Neurophysiol. 2007 Feb;118(2):391-402. doi: 10.1016/j.clinph.2006.09.014. Epub 2006 Nov 29.

    PMID: 17137836BACKGROUND
  • Moustafa IM, Diab AA. The addition of upper cervical manipulative therapy in the treatment of patients with fibromyalgia: a randomized controlled trial. Rheumatol Int. 2015 Jul;35(7):1163-74. doi: 10.1007/s00296-015-3248-7. Epub 2015 Mar 18.

    PMID: 25782585BACKGROUND
  • Haller H, Lauche R, Sundberg T, Dobos G, Cramer H. Craniosacral therapy for chronic pain: a systematic review and meta-analysis of randomized controlled trials. BMC Musculoskelet Disord. 2019 Dec 31;21(1):1. doi: 10.1186/s12891-019-3017-y.

    PMID: 31892357BACKGROUND
  • Licciardone JC, Brimhall AK, King LN. Osteopathic manipulative treatment for low back pain: a systematic review and meta-analysis of randomized controlled trials. BMC Musculoskelet Disord. 2005 Aug 4;6:43. doi: 10.1186/1471-2474-6-43.

    PMID: 16080794BACKGROUND
  • Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Hauser W, Fluss E, Choy E, Kosek E, Amris K, Branco J, Dincer F, Leino-Arjas P, Longley K, McCarthy GM, Makri S, Perrot S, Sarzi-Puttini P, Taylor A, Jones GT. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017 Feb;76(2):318-328. doi: 10.1136/annrheumdis-2016-209724. Epub 2016 Jul 4.

    PMID: 27377815BACKGROUND
  • Ince B, Kara M, Erdem I, Yurdakul OV, Erden T, Aydin T. Effectiveness of spinal manipulation in addition to pharmacological treatment in fibromyalgia: A blinded randomized trial. PM R. 2023 Mar;15(3):342-351. doi: 10.1002/pmrj.12953. Epub 2023 Feb 16.

MeSH Terms

Conditions

Fibromyalgia

Interventions

Manipulation, Spinal

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Musculoskeletal ManipulationsPhysical Therapy ModalitiesTherapeuticsRehabilitation

Study Officials

  • Bugra Ince, MD

    Bezmialem Vakif University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
2 staff members who will administer the treatment to active intervention and sham therapy groups will not be able to be blinded due the inherent of manual therapy. Staff members who are responsible for statistical analysis, participants and outcome assessors will be blinded.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective, triple-blinding, randomized controlled and 3-arm parallel group design clinical study. 3 arms of the study were planned to consist of active intervention group, sham treatment group and no intervention group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD Bugra Ince

Study Record Dates

First Submitted

December 7, 2020

First Posted

December 17, 2020

Study Start

January 26, 2021

Primary Completion

October 15, 2021

Study Completion

October 26, 2021

Last Updated

October 27, 2021

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will not share

Data sharing will be done on request.

Locations